{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:13:50Z","timestamp":1764688430816},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4201,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1111\/j.0022-202x.2004.22606.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T13:55:40Z","timestamp":1104155740000},"page":"1488-1494","source":"Crossref","is-referenced-by-count":35,"title":["Treatment with 5-Fluorouracil and Celecoxib Displays Synergistic Regression of Ultraviolet Light B-Induced Skin Tumors"],"prefix":"10.1016","volume":"122","author":[{"given":"Traci A.","family":"Wilgus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Thomas S.","family":"Breza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen L.","family":"Tober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana M.","family":"Oberyszyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0010","first-page":"207","article-title":"Topical treatment of skin tumours with 5-fluorouracil","volume":"82","author":"Ashton","year":"1970","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/j.1326-5377.1973.tb128666.x","article-title":"Topical use of 5-fluorouracil","volume":"2","author":"Belisario","year":"1973","journal-title":"Med J Aust"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0020","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2133.2002.04720.x","article-title":"Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans","volume":"146","author":"Berhane","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archderm.1976.01630330026006","article-title":"Noninflammatory destruction of actinic keratoses by fluorouracil","volume":"112","author":"Breza","year":"1976","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0030","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/carcin\/19.5.723","article-title":"COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer","volume":"19","author":"Buckman","year":"1998","journal-title":"Carcinogenesis"},{"issue":"Suppl. 1","key":"10.1111\/j.0022-202X.2004.22606.x_bb0035","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/s00280-003-0625-9","article-title":"Thymidylate synthase inhibitors as anticancer agents: From bench to bedside","volume":"52","author":"Chu","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.1963.01590210005001","article-title":"Selective cytotoxic effect of topical 5-Fluorouracil","volume":"88","author":"Dillaha","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2133.1962.tb13497.x","article-title":"Skin changes in patients treated with 5-fluorouracil","volume":"74","author":"Falkson","year":"1962","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/carcin\/bgg046","article-title":"Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice","volume":"24","author":"Fischer","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis","volume":"25","author":"Fischer","year":"1999","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0060","first-page":"1","article-title":"5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp","volume":"6","author":"Gupta","year":"2001","journal-title":"Skin Ther Lett"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0065","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0070","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0075","first-page":"1326","article-title":"Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor","volume":"60","author":"Kishi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4615-0193-0_28","article-title":"Cyclooxygenase-2 in human pathological disease","volume":"507","author":"Koki","year":"2002","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0085","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1097\/01.COC.0000074149.95710.40","article-title":"Celecoxib reduces skin damage after radiation: Selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor","volume":"26","author":"Liang","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0090","first-page":"15","article-title":"Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme","volume":"17","author":"Milas","year":"2003","journal-title":"Oncology (Huntingt)"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0095","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/S0022-5347(05)64237-1","article-title":"Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer","volume":"168","author":"Mizutani","year":"2002","journal-title":"J Urol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02348271","article-title":"Indomethacin augmented antitumor activity of 5-fluorouracil in Meth-A induced mice","volume":"1","author":"Ogino","year":"1996","journal-title":"Int J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s101470050018","article-title":"Indomethacin preferentially augments 5-fluorouracil cytotoxicity in Colon 26 tumors by increasing the intracellular inflow of 5-fluorouracil","volume":"4","author":"Ogino","year":"1999","journal-title":"Int J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0110","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/PL00012088","article-title":"Indomethacin increases the cytotoxicity of cis-platinum and 5-fluorouracil in the human uterine cervical cancer cell lines SKG-2 and HKUS by increasing the intracellular uptake of the agents","volume":"6","author":"Ogino","year":"2001","journal-title":"Int J Clin Oncol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archderm.138.6.751","article-title":"Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: A study in the hairless mouse model","volume":"138","author":"Orengo","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0120","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0190-9622(86)70298-3","article-title":"Weekly pulse dosing schedule of fluorouracil: A new topical therapy for psoriasis","volume":"15","author":"Pearlman","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0125","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/carcin\/20.10.1939","article-title":"Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition","volume":"20","author":"Pentland","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0130","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2133.2003.05033.x","article-title":"Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease","volume":"148","author":"Salim","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0135","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)70287-1","article-title":"Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin","volume":"36","author":"Sander","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2230.1984.tb00862.x","article-title":"Different effects of topically applied 5-fluorouracil on hairy and hairless mice","volume":"9","author":"Tsuji","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mc.10141","article-title":"Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment","volume":"38","author":"Wilgus","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/mc.10142","article-title":"Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer","volume":"38","author":"Wilgus","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0090-6980(00)00089-7","article-title":"Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation","volume":"62","author":"Wilgus","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1111\/j.0022-202X.2004.22606.x_bb0160","first-page":"586","article-title":"Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice","volume":"63","author":"Yao","year":"2003","journal-title":"Cancer Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15308411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T23:58:28Z","timestamp":1586044708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15308411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0022202X15308411"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.22606.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}